S. Uslu Et Al. , "The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Uslu, S. Et Al. 2018. The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry. ARTHRITIS & RHEUMATOLOGY , vol.70 .
Uslu, S., CAN, G., Senel, S., DALKILIÇ, H. E., Inanc, N., Akars, S., ... Kocaer, S. B.(2018). The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry. ARTHRITIS & RHEUMATOLOGY , vol.70.
Uslu, SADETTİN Et Al. "The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Uslu, SADETTİN Et Al. "The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry." ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Uslu, S. Et Al. (2018) . "The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry." ARTHRITIS & RHEUMATOLOGY , vol.70.
@article{article, author={SADETTİN USLU Et Al. }, title={The Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results from the Turkbio Registry}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2018}